The rapid evolution of nanomedicine is transforming how therapeutic molecules are designed, protected, transported and delivered to specific tissues and cells. Advances in lipid nanoparticles, nanocarriers, biomimetic systems, nucleic acid delivery and targeted nanomedicine are opening new possibilities for the development of next-generation medicines.
NANO•DELIVER 2027 is a focused international meeting dedicated to the science, engineering and translation of nanomedicine and nanoscale drug-delivery technologies. The event will bring together researchers from academia, pharmaceutical and biotechnology companies, technology developers, clinicians and regulatory experts to explore how nanoscale engineering can overcome biological barriers and improve therapeutic delivery.
The scientific program will span the complete journey from nanocarrier design and nano–bio interactions to targeting, responsive delivery, manufacturing, safety and clinical translation.
Six scientific sessions
NANO•DELIVER will provide a platform for cutting-edge scientific presentations, emerging technologies, industry perspectives, networking and collaboration, with a particular focus on technologies capable of moving from promising nanoscale concepts toward real therapeutic applications.
The meeting will explore the fundamental question at the heart of modern nanomedicine:
How can we engineer matter at the nanoscale to deliver medicines more precisely, effectively and safely?
NANO•DELIVER 2027 aims to become a leading meeting for scientists and innovators shaping the future of nanoscale drug delivery.
Engineering Delivery at the Nanoscale.